Scholars Central

Research articlePublished 26 Jun 2023

Pharmacokinetic Study of 2 Formulations of GFH009 Maleate Injection in SD Rats

Authors: Fu-Sheng Zhou

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Members of the cyclin-dependent kinase family of proteins have been identified as potential therapeutic targets for suppression of tumor progression due to their role in regulating cell division, proliferation, and growth. Cyclin-Dependent Kinase 9 (CDK9) has been implicated in lymphomas, leukemia and other hematologic malignancies. GFH009, a potent, highly selective inhibitor of CDK9 has been characterized in an acute myelogenous leukemia cell line and demonstrated induced apoptosis. Methods and Findings: This study assessed the Pharmaco Kinetics (PK) of 2 formulations of GFH009, one at pH 4.0 and another at pH 6.0, in Sprague Dawley rats. The mean plasma concentration of each formulation was similar at all time points, peaked at 5 minutes post dose and decreased gradually over time. The ratios of area under the curve from time 0 to infinity, area under the curve from time 0 to the last quantifiable concentration, drug concentration at time zero, clearance, and half-life between the 2 formulations were 0.890, 0.893, 1.02, 1.11 and 0.963, respectively. Conclusion: Although the PK profiles of the 2 formulations were comparable, the pH 6.0 formulation is more appropriate for clinical research because it is closer in pH to that of normal human blood.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in American Journal of Pharmacology and Pharmacotherapeutics.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAmerican Journal of Pharmacology and Pharmacotherapeutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Fu-Sheng Zhou”